Abiopharma

🔍 MULROY DENNIS (Executive)

Company: Arcturus Therapeutics Holdings Inc. (ARCT)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 100,000 shares of Employee Stock Option (right to buy) at $8.63 per share (Derivative)
  Date: 2026-05-01 | Code: A | Expires: 2036-05-01 | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
• F2: The shares underlying this option vest 25% on May 1, 2027, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.